INTRODUCTION {#sec1-1}
============

In the last few decades, implants have become a highly predictable surgical procedure for replacing single or multiple missing teeth. However, in cases of decreased residual bone height, placement of dental implants is an arduous task as insufficient residual bone height increases the probability of injury to vital structures such as maxillary sinus and the inferior alveolar nerve.\[[@ref1]\] In such clinical scenarios, various ridge augmentation procedures such as guided bone regeneration, onlay bone grafting,\[[@ref2]\] lateralization or transposition of the inferior alveolar nerve in atrophic mandible,\[[@ref3]\] and sinus augmentation procedures in posterior atrophic maxilla have been suggested. These procedures are expensive, technically demanding, associated with significant postoperative morbidity, and may require longer rehabilitation periods.

Implants of lesser length have been advocated as a substitute in resorbed ridges to prevent such invasive surgical procedures and reduce postoperative complications and morbidity.\[[@ref4]\] das Neves *et al*.\[[@ref1]\] considered short implants to have an intrabony length of 7--10 mm. However, Renouard and Nisand\[[@ref5]\] have redefined short implants as those that have intrabony length of 8 mm or less. In the present study, implants with 8 mm of intrabony length were considered as short implants. Short implants appear to be a lucrative alternate in cases where adjunctive implant surgeries are needed to place conventional implants. In the past, short implants were associated with lower survival rates.\[[@ref1][@ref6]\] In contrast, studies by Nedir *et al*.,\[[@ref7]\] Telleman *et al*.,\[[@ref8]\] and Annibali *et al*.\[[@ref9]\] have found that success rate of short implants is comparable with implants that are of 10 mm in length or longer. Therefore, the present study was undertaken to evaluate the survival of 8-mm implants, clinically and radiographically, in posterior resorbed ridges.

MATERIALS AND METHODS {#sec1-2}
=====================

The present study was conducted after getting approval from the Institutional Ethics Committee. A written informed consent was obtained from each patient after explaining the study protocol. A total of 11 patients were selected from the department of periodontics using the following criteria.

Inclusion criteria {#sec2-1}
------------------

Patients who were 18 years of age or olderSingle missing tooth in posterior regions of either maxillary and/or mandibular archResidual bone height ranging from 9 to 10 mm between alveolar crest and the floor of the sinus or inferior dental canalAt least 3 months of healing after extractionNatural tooth adjacent to edentulous space needs to have an intact occlusal surface and free from any pathologyPresence of natural opposing teeth or prosthesis.

Exclusion criteria {#sec2-2}
------------------

Presence of untreated periodontal diseases and cariesPatients with a history of systemic disorders such as uncontrolled diabetes mellitus and pregnancy that could affect the outcome of implant therapyPatients with narrow alveolar ridges requiring bone augmentation in planned implant area.

Clinical examination {#sec2-3}
--------------------

Patients\' oral hygiene status was evaluated using Full Mouth Plaque Index (FMPI)\[[@ref10]\] and gingival bleeding was evaluated using Full Mouth Papillary Bleeding Index (FMBI).\[[@ref11]\] These scores were recorded at baseline and 12 months after the final prosthesis. This was carried out to assess oral hygiene status of patients as poor oral hygiene could affect the outcome of implant therapy. Clinically, mesiodistal and buccolingual widths of the alveolar ridge at the edentulous site were measured with the University of North Carolina probe (UNC 15, Hu-Friedy, Chicago, IL, USA).

Radiographic examination {#sec2-4}
------------------------

Preoperative orthopantomogram \[[Figure 1](#F1){ref-type="fig"}\] was taken to assess residual bone height. Digital volumetric tomography (DVT) scan \[[Figure 2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\] was performed at baseline to measure the following:

![Preoperative orthopantomogram](JISP-22-334-g001){#F1}

![(a and b) Preoperative digital volumetric tomography](JISP-22-334-g002){#F2}

In maxillary arch, distance from floor of sinus to crest of the alveolar ridgeIn mandibular arch, from crest of alveolar ridge to inferior dental canalMesiodistal length of the alveolar ridgeBuccopalatal/buccolingual width of the ridgeThickness of buccal and palatal/lingual cortical platesPresence of any septa or sinus pathology/variations in inferior alveolar nerve.

Surgical protocol {#sec2-5}
-----------------

All the dental implants (Equinox, Myriad Plus™ implant system, Equinox Medical Technologies B.V. de Stuwdam, Netherlands) were placed using a two-stage protocol. After flap reflection, osteotomy at implant site was carried out using standard sequential drills depending on the diameter of the implant, under copious irrigation, taking care of the anatomical boundaries. Once the osteotomy site was prepared, the largest and widest possible implant \[[Figure 3](#F3){ref-type="fig"}\] was placed in the recipient site based on preoperative measurements \[[Figure 4](#F4){ref-type="fig"}\]. The flap was positioned over the implant after placement of healing screw. The flap margins were approximated by simple interrupted sutures (silk 3-0, Ethicon, Johnson and Johnson Ltd, Ethicon US LLC). Soft-tissue closure without tension was achieved and the implant remained submerged and was not exposed to oral environment until the second-stage surgery. Immediate postoperative intraoral periapical (IOPA) radiographs were taken to confirm complete seating of the implants \[[Figure 5](#F5){ref-type="fig"}\]. All the patients received antibiotics (capsule amoxicillin, 500 mg 8 hourly) and analgesics (tablet diclofenac 50 mg) twice daily for 5 days after surgery. Chlorhexidine digluconate rinse (Rexidine^®^, Indoco Remedies Ltd, Mumbai, India) was advocated twice a day. Seven to ten days after the surgery, the sutures were removed. Four to six months after implant placement, the second-stage surgery was performed to expose the submerged implant and a gingival former was connected \[[Figure 6](#F6){ref-type="fig"}\] to allow guided soft-tissue healing for 3--4 weeks. Abutment connection was carried out after removal of the gingival former. Single porcelain fused to metal crown was fabricated and all the crowns were cemented \[[Figure 7](#F7){ref-type="fig"}\]. Twelve months following crown placement, the patients were recalled for clinical and radiographic examinations \[Figures [8](#F8){ref-type="fig"} and [9](#F9){ref-type="fig"}\].

![Short implant (8 mm in length)](JISP-22-334-g003){#F3}

![After placement of implant](JISP-22-334-g004){#F4}

![Immediate postoperative intraoral periapical radiograph](JISP-22-334-g005){#F5}

![Connection of gingival former after second-stage surgery](JISP-22-334-g006){#F6}

![After placement of final prosthesis](JISP-22-334-g007){#F7}

![Probing measurements around implants](JISP-22-334-g008){#F8}

![Intraoral periapical radiograph 12 months after final prosthesis](JISP-22-334-g009){#F9}

The following clinical measurements were recorded around each implant: width of keratinized gingiva (WKG), gingival recession (GR), probing pocket depth (PPD), Modified Plaque Index (MPI),\[[@ref12]\] and Modified Bleeding Index (MBI).\[[@ref12]\] Clinical Implant Mobility Scale (CIMS)\[[@ref13]\] was also measured. A periodontal probe (UNC 15, Hu-Friedy, Chicago, IL, USA) was used at four sites (i.e., mesial, buccal, distal, and lingual) around each implant to record PPD and clinical attachment level (CAL). For the probing measurements, the reference line taken into consideration was implant shoulder. All the measurements recorded immediately after placement of crowns were considered as baseline values (T0). The measurements recorded 12 months after crown placement were considered as (T1).

IOPAs were taken at each implant site by paralleling technique with a long cone (XCP Rinn, Dentsply Ltd, Surrey, UK) at baseline (T0) and at 12 months after loading (T1). Following the processing of the IOPAs, a film mounted with a millimeter grid scale (Nix Company Ltd., Tokyo, Japan) was used for radiographic measurements. To measure the changes in the interproximal alveolar crestal bone height, IOPA with printed scale lines was used. From the mesial and distal aspects of each implant, distance from implant shoulder to the most coronal crestal bone in contact with implant (DIB) was measured. The values were expressed in millimeter. For each implant, mean bone loss at mesial and distal sites was calculated at baseline (T0) and at 12 months after loading (T1).

Clinical and radiographic evaluation was performed at 12 months after placement of metal-ceramic restoration. Evaluation for any biological complications such as peri-implant mucositis and peri-implantitis was carried out. Complications such as loosening of abutment screw, chipping of ceramic crown, and fracture of implant were also examined. Albrektsson et al\'s.\[[@ref14]\] success criteria were applied to determine the success or failure of an implant. The criteria included immobile implants, no persistent pain or paresthesia, adequate function, no damage to anatomic structures such as maxillary sinus or inferior alveolar nerve, healthy peri-implant tissue, bone loss at the 1^st^ year should be \< 1.5 mm, and absence of peri-implant radiolucency. The mean for all clinical and radiographic values was calculated for each implant.

RESULTS {#sec1-3}
=======

The present study was performed over a 2-year period. All the selected patients were treated by placement of 8-mm implants (short implants) in residual bone height of 9--10 mm. A second-stage surgery was carried out after 4--6 months to expose the implants for placement of gingival formers followed by placement of abutment and metal-ceramic restorations. A total of 11 systemically healthy patients were recruited. Twelve short implants of length 8 mm were placed using delayed loading protocol \[[Table 1](#T1){ref-type="table"}\]. All the patients reported for follow-up throughout the study. Preoperative measurements at each implant site using DVT scan along with distribution and sizes of implants are mentioned in [Table 2](#T2){ref-type="table"}. All the surgical sites healed uneventfully. The prosthetic rehabilitation was functional and in good condition throughout the study period.

###### 

Patient characteristics

![](JISP-22-334-g010)

###### 

Dimensions of implants and site of implants

![](JISP-22-334-g011)

The FMPI\[[@ref10]\] and FMBI\[[@ref11]\] scores at baseline (T0) and at 12 months (T1) after loading are shown in \[[Table 3](#T3){ref-type="table"}\]. Radiographic bone level at implant site on mesial and distal surfaces at baseline (T0) and 12 months (T1) after final prosthesis is presented in \[[Table 4](#T4){ref-type="table"}\]. All implants showed CIMS of 0 at 12 months after fixed restoration. Measurements of clinical parameters around implants at 12 months after final restoration including mean MPI,\[[@ref12]\] MBI,\[[@ref12]\] PPD, GR, and WKG are shown in \[[Table 5](#T5){ref-type="table"}\].

###### 

Comparison of Full Mouth Plaque Index and Full Mouth Papillary Bleeding Index scores between baseline and at 12 months after loading
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###### 

Radiographic bone levels at implant sites on mesial and distal surfaces at baseline and at 12 months after final restoration
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###### 

Measurement of clinical parameters around implants at 12 months after fixed restoration

![](JISP-22-334-g014)

DISCUSSION {#sec1-4}
==========

The purpose of the present study was to evaluate the survival of short implants of 8 mm in length (short implants) in posterior atrophic regions with single-unit crowns. The study emphasizes the survival of implants of 8 mm in length (short implants) in terms of crestal bone changes around implant and by assessing peri-implant changes using radiographic and clinical parameters, respectively. Plaque accumulation around implants has been shown to induce inflammation and loss of marginal bone.\[[@ref15]\] Good plaque control has been shown to prevent plaque-induced marginal bone loss around implants.\[[@ref16]\] Each patient participating in the study maintained a good oral hygiene level and a healthy clinical gingival condition throughout the study period which was evident by low FMPI, FMPBI, MPI, MBI, and PPD scores. This was the result of the repeated oral hygiene instructions given to the patient. Minimal gingival recession was observed in some cases due to thin gingival biotype. However, recession did not progress in subsequent follow-ups. Prosthetic rehabilitation was functional and in good condition throughout the study period. In the present study, all the implants were well embedded in the bone as revealed by the radiographic analysis. Mean vertical bone loss (DIB) on mesial surface was 1.05 mm, while on distal surface, it was 0.64 mm at 12 months after fixed prosthesis. The greater marginal bone loss during the 1^st^ year could be due to trauma and inflammation to the tissue during surgery. Experiments have shown that the initial necrosis of bone occurs adjacent to the implant. Further bone loss has been observed after loading of implant due to adaptive remodeling to forces until a steady state is established.\[[@ref17]\] Pieri *et al*.\[[@ref18]\] reported mean marginal bone level at the start of prosthetic loading 0.27 mm around short implant of length 6 mm which was decreased to 0.40 mm, 0.51 mm, and 0.60 mm after 6-month and 1- and 2-year follow-up, respectively. Mertens *et al*.\[[@ref19]\] observed bone resorption of 0.24 mm mesially and 0.36 mm distally around short implants of length 8 and 9 mm, respectively, after 10.1 years of implant placement. Anitua *et al*.\[[@ref20]\] reported mean mesial bone loss of 0.88 mm and mean distal bone loss of 0.52 mm around 26 short implants of length 5.5--6.5 mm with a loading period up to 6 months. The findings of our study are in concordance with these studies.

The implant survival rate in the present study using two-stage approach was found to be 100% after a follow-up period of 12 months. These results are comparable with the findings reported in previous studies on short implants. Mertens *et al*.\[[@ref19]\] evaluated the long-term survival of short implants (8 and 9 mm) in severely atrophic alveolar ridges retaining restorations and reported a survival rate of 100%. Grant *et al*.\[[@ref21]\] evaluated the success of short implants (8 mm in length) and reported an implant survival rate of 99% after a follow-up of 2 years. In a systematic review by Karthikeyan *et al*.\[[@ref22]\] on ≤7 mm (published between 1991 and 2011), the survival of short implants was found to increase from 80% to 90% gradually and recent articles show 100% survival. The finding in the present study suggests that the 8-mm short implants can be successfully placed in posterior regions of jaw with reduced bone height. In a meta-analysis of Fan *et al*.,\[[@ref23]\] it was observed that there was no significant difference in the survival rate of short implants (5--8 mm) as compared with long implant group (\>8 mm), with short implant group having lower complications than longer implants. A systematic review and meta-analysis by Lemos *et al*.\[[@ref24]\] comparing short dental implants (≤8 mm) with standard dental implants (\>8 mm) placed in the posterior region of jaw showed that there was no significant difference of implant survival, marginal bone loss, complications, and prosthesis failure. From the above findings of the previous studies, the use of short implants has shown to be a predictable alternative in cases of moderately atrophic mandibles and/or pneumatization of the maxillary sinus.

CONCLUSION {#sec1-5}
==========

The option considered in the present study required only minimally invasive surgery avoiding the need for extensive and traumatic surgical procedures, thus saving treatment costs and time. It can therefore be concluded that use of short implants under strict clinical protocol can be a safe technique with minimal bone resorption and 100% survival at 1-year follow-up. This study will be continued with larger sample size and longer follow-up.
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